XML 58 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) Before Income Taxes
Income before income taxes consists of the following:
Year Ended December 31,
(in millions)202220212020
Domestic$4,439 $8,587 $2,505 
Foreign1,375 (309)(836)
Income before income taxes$5,814 $8,278 $1,669 
Schedule of Income Tax Expense
Income tax expense consists of the following:
Year Ended December 31,
(in millions)202220212020
Federal:
Current$(2,539)$(1,776)$(1,450)
Deferred1,502 250 164 
(1,037)(1,526)(1,286)
State:
Current(32)(228)(198)
Deferred154 (185)97 
122 (413)(101)
Foreign:
Current(232)(185)(155)
Deferred(101)47 (38)
(333)(138)(193)
Income tax expense$(1,248)$(2,077)$(1,580)
Schedule of Difference Between Provision for Income Taxes and Federal Statutory Income Tax Rate to Income Before Provision for Income Taxes
The reconciliation between the federal statutory tax rate applied to Income before income taxes and our effective tax rate is summarized as follows:
Year Ended December 31,
202220212020
Federal statutory rate21.0 %21.0 %21.0 %
State taxes, net of federal benefit(2.0)%2.5 %4.2 %
Foreign earnings at different rates(0.6)%(0.3)%(10.0)%
Research and other credits(2.7)%(1.6)%(6.9)%
US tax on foreign earnings2.7 %1.1 %7.2 %
Foreign-derived intangible income deduction(3.8)%(1.6)%(8.0)%
Settlement of tax examinations(0.2)%(0.7)%(10.2)%
Acquired IPR&D & related charges1.4 %— %56.2 %
Changes in valuation allowance1.2 %1.5 %6.7 %
Non-taxable unrealized loss on investment0.7 %1.8 %23.0 %
Other3.8 %1.4 %11.5 %
Effective tax rate21.5 %25.1 %94.7 %
Schedule of Deferred Tax Assets and Liabilities
Significant components of our deferred tax assets and liabilities are as follows:
December 31,
(in millions)20222021
Deferred tax assets:  
Net operating loss carryforwards$430 $413 
Stock-based compensation95 117 
Reserves and accruals not currently deductible645 700 
Excess of tax basis over book basis of intangible assets1,067 1,157 
Upfront and milestone payments1,298 1,310 
Research and other credit carryforwards233 249 
Equity investments196 129 
Liability related to sale of future royalties278 274 
Capitalized R&D expenditures784 — 
Other, net263 292 
Total deferred tax assets before valuation allowance5,289 4,641 
Valuation allowance(599)(520)
Total deferred tax assets4,690 4,121 
Deferred tax liabilities:
Property, plant and equipment(234)(227)
Excess of book basis over tax basis of intangible assets(5,728)(6,719)
Other(160)(192)
Total deferred tax liabilities(6,122)(7,138)
Net deferred tax assets (liabilities)$(1,432)$(3,017)
Schedule of Unrecognized Tax Benefits Roll Forward
The following is a rollforward of our total gross unrecognized tax benefits:
Year Ended December 31,
(in millions)202220212020
Beginning balance$1,713 $1,614 $2,031 
Tax positions related to current year:
Additions129 147 121 
Reductions— — — 
Tax positions related to prior years:
Additions225 161 398 
Reductions(31)(179)(481)
Settlements(10)(28)(454)
Lapse of statute of limitations(68)(2)(1)
Ending balance$1,959 $1,713 $1,614 
Schedule of Transition Tax
The following table summarizes the anticipated timing of payments associated with this transition tax as of December 31, 2022:
(in millions)Amount
2023$886 
20241,182 
20251,477 
Total$3,546